Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

83.34
-1.8600-2.18%
Volume:5.63M
Turnover:471.93M
Market Cap:209.72B
PE:12.12
High:84.58
Open:84.42
Low:83.23
Close:85.20
Loading ...

AbbVie lifts profit forecast on strong sales of newer immunology drugs

Reuters
·
25 Apr

Wells Fargo Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
25 Apr

Merck & Co Inc (MRK) Q1 2025 Earnings: GAAP EPS of $2.01 and Revenue of $15.5 Billion Surpass Estimates

GuruFocus
·
25 Apr

US business lobby in China: Some pharma firms reporting tariff exemptions

Reuters
·
25 Apr

LIVE MARKETS-Focus on earnings while US and China quibble

Reuters
·
25 Apr

M&A News: Merck KGaA to Buy SpringWorks for $3.5B to Boost Oncology Business

TIPRANKS
·
25 Apr

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

Dow Jones
·
25 Apr

Health Care Up After Merck Earnings -- Health Care Roundup

Dow Jones
·
25 Apr

BUZZ-SpringWorks rises after report Germany's Merck has made nearly $3.5 billion deal

Reuters
·
25 Apr

Germany’s Merck Nears Roughly $3.5 Billion Deal for SpringWorks- WSJ

THOMSON REUTERS
·
25 Apr

Merck and SpringWorks Have Agreed on a Price Close to $47 per Share-WSJ

THOMSON REUTERS
·
25 Apr

BUZZ-Halozyme sues Merck over new version of cancer drug; shares rise

Reuters
·
25 Apr

Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut

Zacks
·
25 Apr

Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

Simply Wall St.
·
25 Apr

Health Care Roundup: Market Talk

Dow Jones
·
25 Apr

Merck Cuts 2025 Outlook on Tariffs, Charges -- Update

Dow Jones
·
25 Apr

BUZZ-U.S. STOCKS ON THE MOVE- PepsiCo, Procter & Gamble

Reuters
·
24 Apr

Global Equities Roundup: Market Talk

Dow Jones
·
24 Apr

Merck's Q1 Earnings Beat Wall Street, Adjusts 2025 Profit Outlook As Tariffs May Result In Incremental Cost Of $200 Million

Benzinga
·
24 Apr

Merck's Challenges with Gardasil in China Continue -- Market Talk

Dow Jones
·
24 Apr